The Oncology Institute, Inc. (TOI)

The Oncology Institute Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	47.4	33.49	14.01	114.3	6	2.45
Short-Term Investments	-	49.37	59.8	-	-	-
Cash & Short-Term Investments	47.4	82.86	73.81	114.3	6	2.45
Cash Growth	-45.77%	12.26%	-35.43%	1805.62%	145.20%	-
Accounts Receivable	54.5	42.36	39.82	20.01	17.15	14.62
Other Receivables	0.36	0.55	0.62	1.24	0.11	0.12
Receivables	54.86	42.91	40.43	21.24	17.26	14.73
Inventory	10.11	13.68	9.26	6.44	4.35	3.89
Prepaid Expenses	4.06	4.05	6.92	11.2	2.11	0.72
Restricted Cash	-	-	-	0.88	-	-
Total Current Assets	116.43	143.49	130.42	154.06	29.72	21.79
Property, Plant & Equipment	39.36	40.05	33.04	4.19	2.1	1.55
Long-Term Investments	-	-	58.35	-	-	-
Goodwill	7.23	7.23	21.42	26.63	14.23	14.08
Other Intangible Assets	15.58	17.9	17.96	18.25	19.52	22
Other Long-Term Assets	0.59	0.56	0.48	0.32	0.12	0.1
Total Assets	179.18	209.24	261.67	203.44	65.69	59.52
Accounts Payable	24.57	14.43	9.37	15.56	12.64	8.89
Accrued Expenses	15.44	7.64	9.42	8.33	4.21	1.48
Current Portion of Long-Term Debt	-	-	-	0.18	5.37	-
Current Portion of Leases	6.75	6.36	5.5	-	-	-
Current Income Taxes Payable	-	-	0.26	0.13	1.14	0.49
Current Unearned Revenue	-	0.55	1.14	0.26	3.38	0.21
Other Current Liabilities	-	5.81	4.04	5.33	1.86	2.52
Total Current Liabilities	46.76	34.79	29.72	29.8	28.61	13.59
Long-Term Debt	91.54	86.83	80.62	-	6.56	-
Long-Term Leases	24.66	26.49	22.06	-	-	-
Long-Term Deferred Tax Liabilities	0.03	0.03	0.11	0.37	1.61	2.96
Other Long-Term Liabilities	0.71	4.08	5.98	69.11	0.81	0.76
Total Liabilities	163.7	152.22	138.49	99.28	37.59	17.3
Common Stock	0.01	0.01	0.01	0.01	0.01	-
Additional Paid-In Capital	214.12	204.19	186.25	167.39	80.4	0.09
Retained Earnings	-197.63	-146.15	-63.08	-63.23	-52.31	-6.02
Treasury Stock	-1.02	-1.02	-	-	-	-
Total Common Equity	15.48	57.03	123.18	104.16	28.1	-5.92
Shareholders' Equity	15.48	57.03	123.18	104.16	28.1	42.22
Total Liabilities & Equity	179.18	209.24	261.67	203.44	65.69	59.52
Total Debt	122.95	119.68	108.18	0.18	11.93	-
Net Cash (Debt)	-75.55	-36.82	-34.37	114.12	-5.93	2.45
Net Cash Per Share	-1.01	-0.50	-0.43	1.72	-0.10	-
Filing Date Shares Outstanding	75.56	74.31	74.55	73.25	-	-
Total Common Shares Outstanding	75.56	74.15	73.27	73.25	-	-
Working Capital	69.67	108.71	100.7	124.26	1.11	8.21
Book Value Per Share	0.20	0.77	1.68	1.42	-	-
Tangible Book Value	-7.33	31.89	83.8	59.29	-5.64	-42
Tangible Book Value Per Share	-0.10	0.43	1.14	0.81	-	-
Machinery	-	5.84	3.88	2.11	1.21	0.77
Construction In Progress	-	1.8	1.14	0.52	0.21	0.03
Leasehold Improvements	-	9.21	6.66	3.39	1.69	1.16

Source: S&P Capital IQ. Standard template. Financial Sources.